Project Grant R01AR085879
- Federal Grant Award Summary Rutgers The State University of New Jersey received a $1.09 million Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective August 7, 2025, with completion targeted for July 31, 2028. The grant funds research to develop gene therapy approaches for LAMA2-related muscular dystrophy through somatic gene amelioration using...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded New Jersey Institute of Technology a $330,107 Project Grant effective September 1, 2025, through June 30, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports fundamental research investigating the role of stress anisotropy—directional stress differences in extracellular matrices—in fibroblast activation and its...
- Project Grant Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $637,018 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded August 7, 2025, with completion targeted for June 30, 2030. The grant funds basic and translational research investigating the role of natural killer (NK)...
- Federal Grant Award Summary Rutgers The State University of New Jersey's School of Nursing received a $762,847 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, through January 31, 2031. The award funds investigator-initiated biomedical research examining the contribution of Type III interferons to the pathogenesis of Staphylococcus aureus infection....
- Federal Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $811,772 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 2, 2026 through May 31, 2031. The award funds investigator-initiated biomedical research aimed at identifying drug tolerance mechanisms in Mycobacterium tuberculosis (MTB) glycerol kinase (GLPK) mutants...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $3.21 million Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded June 1, 2026, with a completion date of May 31, 2030. The award funds a comparative safety research project titled "Mapping Cardiovascular and Infectious Risk of JAK Inhibitors in Patients with Rheumatoid...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey, School of Nursing received a $436,804 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research on novel pediatric tuberculosis (TB) diagnostics. The award, issued on April 17, 2026, with a completion date of March 31, 2028, supports the development and validation of diagnostic approaches utilizing...
- Federal Grant Award Summary The University of Houston System received a $667,276 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective May 20, 2026, with completion anticipated by April 30, 2031. The award funds a research investigation into the genetic and environmental triggers of systemic autoimmune rheumatic diseases (SARDs), including...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $416,121 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 11, 2025, with a completion date of May 31, 2027. This award supports investigator-initiated biomedical research examining the role of TBet+ B cells in viral reinfection and host protection. The research will advance...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Rochester a $547,767 project grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) effective June 1, 2026, through May 31, 2031. This research initiative focuses on identifying host mechanisms governing Staphylococcus aureus persistence during implant-associated osteomyelitis, a significant clinical challenge in...
Rutgers The State University of New Jersey's School of Nursing received a $237,489 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective June 1, 2026, with a completion date of April 30, 2029. The award funds the Study to Probe and Assess Registry-Claims Linkage for Juvenile Idiopathic Arthritis (SPARCLE-JIA), which will create and evaluate a linked dataset combining clinical data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry with healthcare claims data from the Komodo National Claims Database covering over 50,000 children and youth diagnosed with juvenile idiopathic arthritis (JIA). The primary deliverables include a comprehensive analysis comparing patient characteristics between linked and unlinked registry and claims datasets, validation studies examining the accuracy of linked data for clinical outcomes such as uveitis and infection-related hospitalizations, and proof-of-concept research investigating the relationship between biologic drug dispensing delays and disease activity. SPARCLE-JIA employs advanced analytical approaches to address critical data gaps in pediatric rheumatology research by integrating detailed clinical measures and patient-reported outcomes from the registry with population-based healthcare utilization and medication dispensing data from claims databases, thereby enabling more rigorous and broadly applicable observational and interventional clinical studies on JIA management and treatment efficacy.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $237.5k | 5/29/26 |